OncoSec Medical Inc P/E
Quel est le P/E de OncoSec Medical Inc?
Le P/E de OncoSec Medical Inc est 0.00
Quelle est la définition de P/E?
Le ratio cours / bénéfice est le rapport entre le prix des actions d'une entreprise et le bénéfice par action de l'entreprise calculé sur les douze derniers mois.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E des entreprises dans Health Care secteur sur NASDAQ par rapport à OncoSec Medical Inc
Que fait OncoSec Medical Inc?
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
Entreprises avec p/e similaire à OncoSec Medical Inc
- Richland Resources International a P/E de N/A
- Safeplus International a P/E de N/A
- China Yanyuan Yuhui Natl Ed Grp a P/E de N/A
- Acusphere a P/E de N/A
- American Oriental Bioengineering a P/E de N/A
- Gourmet Provisions International a P/E de N/A
- OncoSec Medical Inc a P/E de 0.00
- SEL Manufacturing a P/E de 0.00
- China Zhong Qi Hldgs a P/E de 0.00
- MedSmart a P/E de 0.00
- Panbela Therapeutics a P/E de 0.00
- Epic a P/E de 0.00
- 2574 a P/E de 0.00